Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FSPN5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,897
Award facts
- Contract value 100% obligated
- $54,897.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $54,897.24 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg in a 2-pen/mL dose formulation, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle through December 2026 that serves as a comprehensive pharmaceutical support arrangement for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated its capability to meet federal medical procurement requirements through its extensive portfolio of delivery orders with the Defense Logistics Agency. The SPE2DX contract enables the company to supply a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Cosentyx reflects the company's ongoing role in providing critical immunosuppressive medications and specialty pharmaceutical products to the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FSPN5?
SPE2DB25FSPN5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FSPN5 worth?
The government has obligated $54,897 on SPE2DB25FSPN5.
Is contract SPE2DB25FSPN5 an order under another contract?
Yes. SPE2DB25FSPN5 is a delivery order under SPE2DB20D7061, an indefinite delivery contract.
Was contract SPE2DB25FSPN5 competed?
The extent of competition for SPE2DB25FSPN5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award